Loading...
Olaparib
India Pharmaceutical Trade Intelligence
Who Supplies Olaparib to India from UNITED STATES
India's olaparib imports from UNITED STATES total $263.9K across 16 shipments from 9 foreign suppliers. SUN PHARMACEUTICAL INDUSTRIES INC. leads with $159.0K in import value; the top 5 suppliers together control 89.0% of this origin. Leading Indian buyers include SUN PHARMACEUTICAL INDUSTRIES LIMITED. This corridor reflects India's pharmaceutical import demand for olaparib — a diversified sourcing base with multiple active suppliers from UNITED STATES.
Top foreign suppliers (UNITED STATES) — Ranked by import value
SUN PHARMACEUTICAL INDUSTRIES INC. is the leading Olaparib supplier from UNITED STATES to India, with import value of $159.0K across 6 shipments. The top 5 suppliers — SUN PHARMACEUTICAL INDUSTRIES INC., NEW LIFE MEDICALS (USA) INC., NewLife Medicals (USA). Inc., ADIRAMEDICA LLC, ESPEE BIOPHARMA AND FINECHEM LLC — collectively account for 89.0% of total import value from this origin.
Top foreign suppliers (UNITED STATES)
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES INC. | $159.0K | 6 | 60.2% |
| 2 | NEW LIFE MEDICALS (USA) INC. | $24.8K | 1 | 9.4% |
| 3 | NewLife Medicals (USA). Inc. | $17.9K | 1 | 6.8% |
| 4 | ADIRAMEDICA LLC | $16.7K | 1 | 6.3% |
| 5 | ESPEE BIOPHARMA AND FINECHEM LLC | $16.3K | 2 | 6.2% |
| 6 | ESPEE BIOPHARMA & FINECHEM LLC | $16.3K | 2 | 6.2% |
| 7 | ESPEE BIOPHARMA FINECHEM LLC | $8.7K | 1 | 3.3% |
| 8 | BILCARE GCS INC. | $4.2K | 1 | 1.6% |
| 9 | Pharmaceutical Buyers, Inc. | $0 | 1 | 0.0% |
Showing top 9 of 9 foreign suppliers · Indian Customs (DGFT) · TransData Nexus
Top Indian buyers (importing from UNITED STATES)
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $159.0K | 6 | 60.2% |
| 2 | ZYDUS LIFESCIENCES LIMITED | $24.8K | 1 | 9.4% |
| 3 | ALEMBIC PHARMACEUTICALS LIMITED | $17.9K | 1 | 6.8% |
| 4 | DR.REDDY'S LABORATORIES LIMITED | $16.7K | 1 | 6.3% |
| 5 | EUGIA PHARMA SPECIALITIES LIMITED | $16.3K | 2 | 6.2% |
| 6 | INTAS PHARMACEUTICALS LIMITED | $16.3K | 2 | 6.2% |
| 7 | CIPLA LIMITED | $8.7K | 1 | 3.3% |
| 8 | DR.REDDY'S LABORATORIES LTD | $4.2K | 1 | 1.6% |
| 9 | MYLAN LABORATORIES LIMITED | $0 | 1 | 0.0% |
Import Statistics
- Import Value
- $263.9K
- Shipments
- 16
- Foreign Suppliers
- 9
- Indian Buyers
- 9
- Avg. Shipment
- $16.5K
Other Olaparib Import Origins
Frequently Asked Questions — Olaparib Imports from UNITED STATES
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
QWho are the top Olaparib suppliers from UNITED STATES to India?
The top Olaparib suppliers from UNITED STATES to India include SUN PHARMACEUTICAL INDUSTRIES INC., NEW LIFE MEDICALS (USA) INC., NewLife Medicals (USA). Inc.. The leading supplier is SUN PHARMACEUTICAL INDUSTRIES INC. with import value of $159.0K USD across 6 shipments. India imported Olaparib worth $263.9K USD from UNITED STATES in total across 16 shipments.
QHow much Olaparib does India import from UNITED STATES?
India imported Olaparib worth $263.9K USD from UNITED STATES across 16 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
QWho are the main Indian buyers of Olaparib from UNITED STATES?
The main Indian buyers of Olaparib sourced from UNITED STATES include SUN PHARMACEUTICAL INDUSTRIES LIMITED, ZYDUS LIFESCIENCES LIMITED, ALEMBIC PHARMACEUTICALS LIMITED. The largest buyer is SUN PHARMACEUTICAL INDUSTRIES LIMITED with $159.0K in imports across 6 shipments.
QWhat is the total value of Olaparib imports from UNITED STATES to India?
The total value of Olaparib imports from UNITED STATES to India is $263.9K USD, across 16 shipments and 9 foreign suppliers. Data source: Indian Customs (DGFT).
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
SS
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: UNITED STATES to India pharmaceutical import trade corridor identified from Indian Customs (DGFT) shipping bill records for Olaparib.
- 2.Supplier/Buyer Matching: 9 foreign suppliers from UNITED STATES and 9 Indian buyers identified using company name normalization across customs records.
- 3.Value Aggregation: Total import value of $263.9K aggregated from 16 verified shipping bill records. All values reported in FOB USD as recorded by Indian Customs.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
16 Verified Shipments
9 suppliers, 9 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists